Skip to main content
. 2025 Sep 11;13:e75326. doi: 10.2196/75326

Table 3.

Sensitivity analyses for calculating incremental cost-effectiveness ratios during the within-trial period.

Additional scenario analysis Range of valuesa Cost per mmHg SBPb changec ($) Cost per QALYd gainedc ($)


Low High Low High
Changes in effectiveness-related parameters

Systolic blood pressure reduction, mmHge 1.0-4.7 5.2 23.0 N/Af N/A

Difference in QALYs between 2 groupse 0.02-0.04 N/A N/A 603.4 1206.8

Incremental mean medication adherence 0.01-0.04 6.3 8.6 694.1 942.7
Changes in cost-related parameters ($)





Compensation for township physiciansg 572.4-1717.1 8.1 8.8 805.5 870.3

Compensation for village doctorsg 5194.9-15554.9 5.4 11.2 539.4 1114.8

Compensation for local project manager 370.4-1111.1 8.2 8.5 812.7 855.9

Compensation for county specialists 134.65-403.95 8.3 8.4 823.5 837.9

Voice messages 774.4-2323.2 8.1 8.8 805.5 873.9

Printing materials 168.35-505.05 8.4 8.4 834.3 837.9

System maintenance and management costs per year 740.7-2222.1 7.9 8.7 784.0 866.7

Intervention development fee 8248.8-24,746.4 3.8 13.0 381.2 1294.6

Incremental annual medication cost 2.6-7.8 7.5 12.9 692.6 975.1

Incremental annual hospitalization cost –48.6 to 16.2 4.8 16.7 298.7 1363.9

aThe range was defined as a 50% decrease or increase from the base case for key parameters, except for systolic blood pressure reduction and difference in QALYs between 2 groups.

bSBP: systolic blood pressure.

cCalculated based on the 5000 bootstrapping and adjusted for baseline outcome, township, sex, and age.

dQALY: quality-adjusted life year.

eRange values are the bounds of the 95% CIs from the primary outcome analysis in the SINEMA trial.

fNot applicable.

gPresented as the average cost for township physicians and village doctors including performance-based incentives.